Question 1

What is the catalog number for Dactylorhin A?

Accepted Answer

The catalog number for Dactylorhin A is M24152.

Question 2

What sizes are available for Dactylorhin A?

Accepted Answer

Dactylorhin A is available in the following size(s): 1 g, 200 mg, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does Dactylorhin A come in?

Accepted Answer

Dactylorhin A is available in 8 different pack sizes.

Question 4

Is Dactylorhin A in stock?

Accepted Answer

Dactylorhin A is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Dactylorhin A used for?

Accepted Answer

Dactylorhin A, a succinate derivative ester, is isolated from rhizomes of Gymnadenia conopsea. Dactylorhin A exhibits moderate inhibitory effect on NO production effects in RAW 264.7 macrophage cells.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 8

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Dactylorhin A

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

MYO1G Antibody, HRP conjugated

MYO1G Antibody, HRP conjugated

Oxelumab

Oxelumab

Oxelumab

Oxelumab